Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 2
1987 4
1988 1
1989 3
1990 5
1991 4
1992 1
1993 2
1994 3
1995 2
1996 1
1997 2
1999 3
2000 1
2001 1
2006 2
2009 2
2010 2
2011 2
2012 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity.
Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao JR, James MJ, Abin-Fuentes A, Momin M, Bergeron C, Fisher A, Miller PF, West KA, Lora JM. Leventhal DS, et al. Among authors: miller pf. Nat Commun. 2020 Jun 1;11(1):2739. doi: 10.1038/s41467-020-16602-0. Nat Commun. 2020. PMID: 32483165 Free PMC article.
Linezolid, the first oxazolidinone antibacterial agent.
Leach KL, Brickner SJ, Noe MC, Miller PF. Leach KL, et al. Among authors: miller pf. Ann N Y Acad Sci. 2011 Mar;1222:49-54. doi: 10.1111/j.1749-6632.2011.05962.x. Ann N Y Acad Sci. 2011. PMID: 21434942 Review.
Bacterial uptake of aminoglycoside antibiotics.
Taber HW, Mueller JP, Miller PF, Arrow AS. Taber HW, et al. Among authors: miller pf. Microbiol Rev. 1987 Dec;51(4):439-57. doi: 10.1128/mr.51.4.439-457.1987. Microbiol Rev. 1987. PMID: 3325794 Free PMC article. Review. No abstract available.
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.
Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, Wagner DA, West KA, Degar AJ, Brennan AM, Miller PF. Kurtz CB, et al. Among authors: miller pf. Sci Transl Med. 2019 Jan 16;11(475):eaau7975. doi: 10.1126/scitranslmed.aau7975. Sci Transl Med. 2019. PMID: 30651324 Clinical Trial.
51 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page